Logo
Oladoctor – online healthcare marketplace in Spain

Medicamentos de Daiichi Sankyo Europe Gmbh en Spain

V
VANFLYTA 17.7 mg FILM-COATED TABLETS
Dosage form:  TABLET, 17.7 mg
Active substance:  quizartinib
Manufacturer:  Daiichi Sankyo Europe Gmbh
Prescription required
VANFLYTA 26.5 mg FILM-COATED TABLETS
Dosage form:  TABLET, 26.5 mg
Active substance:  quizartinib
Manufacturer:  Daiichi Sankyo Europe Gmbh
Prescription required
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.
Follow us on social media